Traitement des tumeurs de la vessie par les inhibiteurs du contrôle immunitaire

Elisabeth Grobet-Jeandin, Ugo Pinar, Yohann Loriot, Morgan Roupret

Résultats de recherche: Contribution à un journalArticleRevue par des pairs

1 Citation (Scopus)

Résumé

Checkpoint inhibitors could lead to a significant improvement in the management of bladder cancer. For metastatic bladder cancer, checkpoint inhibitors showed an improved overall survival and are currently recommended in second intention. Moreover, they could be used in replacement of standard chemotherapy in the case of muscle-invasive tumors. Finally, they appear to decrease the risk of recurrence after initial BCG treatment failure in the case of non-muscle-invasive tumors. For these three diseases forms, numerous ongoing trials are striving to demonstrate checkpoint inhibitors value.

Titre traduit de la contributionTREATMENT OF BLADDER CANCER WITH IMMUNE CHECKPOINTS INHIBITORS
langue originaleFrançais
Pages (de - à)391-395
Nombre de pages5
journalRevue du Praticien
Volume71
Numéro de publication4
étatPublié - 1 avr. 2021
Modification externeOui

Contient cette citation